Lozano-Gil, Juan M https://orcid.org/0000-0002-0422-9887
Rodríguez-Ruiz, Lola https://orcid.org/0000-0002-7559-8444
Palacios, Manuel https://orcid.org/0000-0002-2172-1259
Peral, Jorge
Navarro, Susana
Fuster, José L https://orcid.org/0000-0002-4881-9440
Beléndez, Cristina
Jérez, Andrés
Murillo-Sanjuán, Laura
Díaz-de-Heredia, Cristina https://orcid.org/0000-0001-8086-296X
López-de-Hontanar, Guzmán https://orcid.org/0000-0002-1124-4954
Zubicaray, Josune
Sevilla, Julián
Ferrer-Marín, Francisca
Sepulcre, María P
Cayuela, María L https://orcid.org/0000-0002-2021-9822
García-Moreno, Diana https://orcid.org/0000-0002-1521-2327
Martínez-López, Alicia https://orcid.org/0000-0003-3347-0394
Tyrkalska, Sylwia D https://orcid.org/0000-0001-6654-0163
Mulero, Victoriano https://orcid.org/0000-0001-9527-0211
Funding for this research was provided by:
Fundación Séneca (21887/PI/22)
Fundación Séneca (22242/PDC/23)
Ministerio de Ciencia, Innovación y Universidades (2020-113660RB-I00)
Ministerio de Ciencia, Innovación y Universidades (Juan de la Cierva)
MEC | Instituto de Salud Carlos III (CP21/00028)
MEC | Instituto de Salud Carlos III (CP23/00049)
MEC | Instituto de Salud Carlos III (ER24P7AC7682-ACCI23-12-7682)
Region of Murcia | Consejería de Sanidad y Política Social, Comunidad Autónoma de la Región de Murcia (ZEBER)
Diamond Blackfan Anemia Foundation
Article History
Received: 5 March 2025
Revised: 8 December 2025
Accepted: 10 December 2025
First Online: 9 January 2026
Disclosure and competing interests statement
: A patent for the use of ZAKα inhibitors to treat anemia has been registered by Universidad de Murcia, IMIB Pascual Parrilla, and CIBERER (#P201831288).